50% discount for students on Physiology exam guides e-books
Use Code 6HDXXAA on checkout.
visit the link below or copy paste in your browser-
https://physiologytc.gumroad.com/l/qnerjg
Physiology is the study of functions of living body. Every body is made up of cells which constitute tissues that make organs and that make systems. These perform various functions. The optimum levels of these functions is called Homoeostasis. The internal environment of body is called miliu interior.
50% discount for students on Physiology exam guides e-books
Use Code 6HDXXAA on checkout.
visit the link below or copy paste in your browser-
https://physiologytc.gumroad.com/l/qnerjg
Melatonin,
an indoleamine, is a natural compound produced by various organisms, including
bacteria and eukaryotes. In 1917, Carey Pratt McCord and Floyd P. Allen found
that feeding extracts from the pineal glands of cows caused the skin of
tadpoles to lighten by contracting the dark epidermal melanophores.
The hormone
melatonin was isolated from
bovine pineal gland extracts in 1958 by Aaron B. Lerner, a dermatology
professor, and his team at Yale University. Lerner and his colleagues proposed the name melatonin,
derived from the Greek words melas, meaning 'black' or 'dark', and tonos,
meaning 'labour', 'colour' or 'suppress' as it was found to lighten skin
colour. Subsequent research in the
mid-1970s by Lynch and others demonstrated that melatonin production follows a
circadian rhythm in human pineal glands. This compound was later identified as
a hormone secreted in the brain during the night, playing a crucial role in
regulating the sleep-wake cycle, also known as the circadian rhythm, in human.
Biosynthesis
The
biosynthesis of melatonin in animals involves a sequence of enzymatic reactions
starting with L-tryptophan, which can be synthesized through the shikimate
pathway from chorismate, found in plants, or obtained from protein catabolism.
The initial step in the melatonin biosynthesis pathway is the hydroxylation of
L-tryptophan's indole ring by the enzyme tryptophan hydroxylase, resulting in
the formation of 5-hydroxytryptophan (5-HTP). Subsequently, 5-HTP undergoes
decarboxylation, facilitated by pyridoxal phosphate and the enzyme
5-hydroxytryptophan decarboxylase, yielding serotonin.
Serotonin, itself
an essential neurotransmitter, is further converted into N-acetylserotonin by
the action of serotonin N-acetyltransferase, using acetyl-CoA. The final step
in the pathway involves the methylation of N-acetylserotonin's hydroxyl group
by hydroxyindole O-methyltransferase, with S-adenosyl methionine as the methyl
donor, to produce melatonin.
Regulation
of secretion
In human,
the secretion of melatonin is regulated through the activation of the beta-1
adrenergic receptor by the hormone norepinephrine. Norepinephrine increases the
concentration of intracellular cAMP via beta-adrenergic receptors, which in
turn activates the cAMP-dependent protein kinase A (PKA). PKA then
phosphorylates arylalkylamine N-acetyltransferase (AANAT), the penultimate
enzyme in the melatonin synthesis pathway. When exposed to daylight,
noradrenergic stimulation ceases, leading to the immediate degradation of the
protein by proteasomal proteolysis.
Blue light,
especially within the 460–480 nm range, inhibits the biosynthesis of melatonin,
with the degree of suppression being directly proportional to the intensity and
duration of light exposure. Historically, humans in temperate climates
experienced limited exposure to blue daylight during winter months, primarily
receiving light from sources that emitted predominantly yellow light, such as
fires. The incandescent light bulbs used extensively throughout the 20th
century emitted relatively low levels of blue light. It has been found that
light containing only wavelengths greater than 530 nm does not suppress
melatonin under bright-light conditions. The use of glasses that block blue
light in the hours preceding bedtime can mitigate melatonin suppression.
Additionally, wearing blue-blocking goggles during the last hours before
bedtime is recommended for individuals needing to adjust to an earlier bedtime
since melatonin facilitates the onset of sleep.
Metabolism
Melatonin is
metabolized in liver by liver enzymes, with an elimination half-life ranging
from 20 to 50 minutes. The primary metabolic pathway transforms melatonin into
6-hydroxymelatonin, which is then conjugated with sulfate and excreted in urine
as a waste product.
Measurement
For both
research and clinical purposes, melatonin levels in humans can be determined
through saliva or blood plasma analysis.
Physiological
functions
Circadian
rhythm
In human,
melatonin is critical for the regulation of sleep–wake cycles, or circadian
rhythms. The establishment of regular melatonin levels in human infants occurs
around the third month after birth, with peak concentrations observed between
midnight and 8:00 am. It has been documented that melatonin production
diminishes as a person ages. Additionally, a shift in the timing of melatonin
secretion is observed during adolescence, resulting in delayed sleep and wake
times, increasing their risk for delayed sleep phase disorder during this
period.
Antioxidant
Properties
The
antioxidant properties of melatonin were first recognized in 1993. In vitro
studies reveal that melatonin directly neutralizes various reactive oxygen
species, including hydroxyl (OH•), superoxide (O2−•), and reactive nitrogen
species such as nitric oxide (NO•).
Melatonin's
concentration in the mitochondrial matrix is significantly higher than that
found in the blood plasma, emphasizing its role not only in direct free radical
scavenging but also in modulating the expression of antioxidant enzymes and
maintaining mitochondrial integrity. This multifaceted role shows the
physiological significance of melatonin as a mitochondrial antioxidant, a
notion supported by numerous scholars.
Furthermore,
the interaction of melatonin with reactive oxygen and nitrogen species results
in the formation of metabolites capable of reducing free radicals. These
metabolites, including cyclic 3-hydroxymelatonin,
N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), and
N1-acetyl-5-methoxykynuramine (AMK), contribute to the broader antioxidative
effects of melatonin through further redox reactions with free radicals.
Immune
system
Melatonin's
interaction with the immune system is recognized, yet the specifics of these
interactions remain inadequately defined. An anti-inflammatory effect appears
to be the most significant. The efficacy of melatonin in disease treatment has
been the subject of limited trials, with most available data deriving from
small-scale, preliminary studies. It is posited that any beneficial
immunological impact is attributable to melatonin's action on high-affinity
receptors (MT1 and MT2), which are present on immunocompetent cells.
Preclinical investigations suggest that melatonin may augment cytokine
production and promote the expansion of T cells, thereby potentially mitigating
acquired immunodeficiencies.
Weight
regulation
Melatonin's
potential to regulate weight gain is posited to involve its inhibitory effect
on leptin, a hormone that serves as a long-term indicator of the body's energy
status.
Use as a
medication and supplement
As a
medicine it is used in following conditions under medical supervision-
1.
Insomnia- in persons above 55 years
2.
Circadian rhythm sleep disorders like- delayed sleep phase syndrome and to reduce jet lag syndrome
3.
REM sleep behavior disorders- like Parkinson's disease and dementia
with Lewy bodies.
4.
Dementia- melatonin may improve sleep in minimal cognitive impairment
only in cases of dementia.
The American Diabetes Association (ADA) has released its highly anticipated "Standards of Care in Diabetes—2026," marking another year of comprehensive updates to the gold standard in diabetes management. Published in January 2026, these guidelines reflect the latest scientific research and clinical evidence designed to improve outcomes for the millions of people living with diabetes and prediabetes worldwide.
The ADA's Standards of Care represents significant advancement in the delivery of evidence-based, person-centered care, synthesizing the latest scientific research with practical clinical strategies to equip healthcare professionals with tools necessary to provide optimal care for individuals living with diabetes. The guidelines include strategies for diagnosing and treating diabetes in children, adolescents, and adults, methods to prevent or delay diabetes and its associated comorbidities like obesity, and care recommendations to enhance health outcomes.
The 2026 Standards of Care are accessible through multiple channels to ensure clinicians and patients can access current information:
One of the most significant changes in the 2026 guidelines is the emphasis on earlier access to advanced diabetes technologies.
Continuous Glucose Monitoring (CGM)
The 2026 updates include expanded recommendations for technology use, such as continuous glucose monitoring (CGM) and automated insulin delivery (AID). The updated guidelines now recommend CGM use at the onset of diabetes for those using insulin and for anyone at risk of hypoglycemia or who would benefit from CGM in supporting blood sugar management.
CGM is encouraged at diagnosis with earlier access, and over-the-counter CGMs are acknowledged as useful for people with prediabetes or type 2 diabetes wanting lifestyle feedback. Additionally, in people with diabetes on insulin therapy, CGM devices should be used as close to daily as possible for maximal benefit, with uninterrupted access to supplies to minimize gaps in CGM.
Automated Insulin Delivery (AID)
A major change in 2026 is the recommendation of AID systems as the preferred insulin delivery system for all people with type 1 diabetes and children and adults with type 2 diabetes who use insulin. Notably, the updated advice specifies that there should be no requirement of C-peptide level, presence of islet autoantibodies or duration of insulin treatment before initiation of insulin pumps or automated systems. This removes previous barriers to accessing these life-changing technologies.
The ADA Standards recognize open-source AID systems—such as AndroidAPS, Loop, iAPS, and Trio—as part of mainstream diabetes care, with an encouragement for clinicians to engage rather than avoid patient-driven technology.
For the first time, the 2026 Standards support GLP-1s and similar drugs for people with type 1 diabetes. This represents a paradigm shift in type 1 diabetes management. A major change in the 2026 edition is the new support of GLP-1 and similar drugs for use in adults with type 1 diabetes with a body mass index (BMI) greater than 30 (27.5 for Asian Americans).
For type 2 diabetes patients with comorbidities, the guidelines also suggest broader access for GLP-1-based medicines because of their benefits beyond glucose management and weight. Additionally, GLP-1 medications are now recommended as the initial therapy for adults with type 2 diabetes and liver fibrosis and MASLD (metabolic dysfunction-associated steatotic liver disease).
The 2026 guidelines place increased emphasis on managing metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). The guidelines now address liver disease, including MASH (metabolic dysfunction-associated steatohepatitis), an advanced form of liver disease marked by excess fat in the liver, which is common in type 2 diabetes and has implications for heart and kidney health.
The guidelines recommend that individuals with kidney disease may need testing more often, in consultation with their healthcare provider. The guidelines reaffirm blood pressure goals, recommending levels below 130/80 mmHg for most people with diabetes, and aiming for even lower systolic blood pressure when it can be done safely.
A more aggressive approach to weight management is now recommended. Lifestyle plans involving diet, physical activity, and other health behaviors should aim for a weight loss target of 5–7% of baseline body weight, demonstrating increased emphasis on obesity as a primary target for intervention.
The 2026 Standards represent a significant shift in nutritional guidance. Rather than recommending small, frequent high-carbohydrate meals, the new guidelines propose a range of potential eating patterns that fall under the broader umbrella of low-carbohydrate/lower starch diets, including the Mediterranean, plant-based, and the Dietary Approaches to Stop Hypertension (DASH) diet as options that can support patients' overall health.
Mediterranean and low-carbohydrate diets are specified as having the best evidence for preventing or delaying onset of type 2 diabetes in high-risk individuals.
The guidelines maintain emphasis on regular physical activity for blood glucose management and overall health. For adults with diabetes, the recommendation is to engage in 150 minutes or more of moderate- to vigorous-intensity aerobic activity per week, spread over at least 3 days/week, with no more than 2 consecutive days without activity. Additionally, prolonged sitting should be interrupted at least every 30 minutes for blood glucose and other benefits.
The 2026 Standards place greater emphasis on mental health support and screening, recognizing the psychological burden of diabetes management. The guidelines include guidance on behavioral health screening and referral for concerns such as diabetes distress and anxiety, with recommendations for annual screening for anxiety and fear of hypoglycemia in those at risk.
A foundational principle throughout the 2026 Standards is person-centered care. The Standards of Care stress the importance of coordinated interprofessional teams, which include physicians, diabetes educators, dietitians, pharmacists, and mental health counselors, in guiding diabetes patient care.
The guidelines emphasize that care systems should facilitate in-person and virtual team-based care, include those knowledgeable and experienced in diabetes management as part of the team, and utilize patient registries, decision support tools, proactive care planning, and community involvement to meet needs of individuals with diabetes.
To support clinicians in implementing these guidelines, the ADA partnered with the artificial intelligence initiative OpenEvidence to create a tool that will allow physicians to ask the Standards of Care specific questions and receive clinically backed answers, available free of charge for healthcare professionals registered with the ADA.
The 2026 Standards operate as "living guidelines," meaning they are continuously updated throughout the year as new evidence emerges. The online version, abridged guidelines, and all related materials will be updated in real time throughout the year to reflect the latest evidence and regulatory changes.
The 2026 Standards have received endorsements from numerous professional organizations, reflecting their comprehensive and evidence-based nature. For the eighth consecutive year, section 10 on "Cardiovascular Disease and Risk Management," received endorsement from the American College of Cardiology. For the second consecutive year, section 13 on "Older Adults" received endorsement from the American Geriatrics Society. For the first time, section 11 on "Chronic Kidney Disease and Risk Management" and section 14 on "Children and Adolescents" received endorsement from the National Kidney Foundation and the International Society for Pediatric and Adolescent Diabetes, respectively.
The 2026 Standards represent a shift toward:
Earlier intervention: Technologies and therapies are now recommended at diagnosis rather than as last resorts.
Broader access: Removed prerequisites for advanced therapies ensure more patients can benefit from newer treatments.
Personalization: Guidelines emphasize individualized approaches based on patient values, preferences, and comorbidities.
Technology integration: Recognition that patient-driven innovations are part of mainstream care.
Holistic health: Greater attention to mental health, lifestyle, and comorbidity management alongside glucose control.
The 2026 "Standards of Care in Diabetes" represents significant advancement in the delivery of evidence-based, person-centered care, equipping healthcare professionals with the tools necessary to provide optimal care for individuals living with diabetes. With emphasis on technology adoption, broader GLP-1 use, personalized nutrition, and team-based care, these guidelines mark a significant evolution in diabetes management.
Healthcare providers and patients should familiarize themselves with these updated recommendations through the various resources available, from the full text to mobile apps and quick-reference guides. The goal remains consistent across all changes: to improve health outcomes and quality of life for the millions of people affected by diabetes.
American Diabetes Association. "Standards of Care in Diabetes—2026." Diabetes Care, January 2026. https://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-standards-care-diabetes-2026
American Diabetes Association Professional Practice Committee for Diabetes. "Summary of Revisions: Standards of Care in Diabetes—2026." Diabetes Care, Vol. 49, Supplement 1, January 2026. https://diabetesjournals.org/care/article/49/Supplement_1/S6/163930/
Professional Diabetes Association. "Standards of Care in Diabetes - ADA Clinical Guidelines." https://professional.diabetes.org/standards-of-care
DiaTribe. "Your Guide to the 2026 ADA Standards of Care." December 2025. https://diatribe.org/diabetes-management/your-guide-2026-ada-standards-care
DiabetesOnTheNet. "Factsheet - 2026 ADA Standards." https://diabetesonthenet.com/diabetes-primary-care/factsheet-2026-ada-standards/
MedCentral. "The 2026 ADA Standards of Care in Diabetes Embrace Technology to Support Holistic Care." December 2025. https://www.medcentral.com/endocrinology/diabetes/the-2026-ada-standards-of-care-in-diabetes-embrace-technology-to-support-holistic-care
Guideline Central. "2026 ADA Diabetes Standards of Care Guideline — New Recommendations." December 2025. https://www.guidelinecentral.com/insights/dec-2025-ada-diabetesstandardsofcare-guideline-spotlight/
Diabetotech. "Key Updates: ADA 2026 Diabetes Technology Guidelines." https://www.diabetotech.com/blog/key-updates-ada-2026-diabetes-technology-guidelines
ACP Diabetes Monthly. "ADA's Standards of Care for 2026 released." December 2025. https://www.acpjournals.org/doi/10.7326/acpd-20251212_1
Disclaimer: This blog post is for informational purposes only and should not be considered medical advice. Individuals should consult with their healthcare provider for personalized diabetes management recommendations.
Last Updated: January 2026
Preparing for a medical entrance examination is not merely about
memorizing textbooks or solving endless question papers. It is a long-term
intellectual, emotional, and psychological journey that demands discipline,
consistency, strategic planning, and resilience. Medical entrance exams—such as
NEET (India), MCAT (USA), or similar national-level tests in other
countries—are designed to assess not only knowledge but also conceptual
clarity, analytical ability, and stamina.
This article presents a step-by-step, realistic, and student-centered
roadmap to help aspirants prepare effectively and sustainably for medical
entrance exams.
1. Understand the Nature of the Exam
Before opening a single book, you must clearly understand:
Why This Matters
Many students waste precious months studying irrelevant material or
overemphasizing low-weightage topics. A precise understanding of the syllabus
ensures focused preparation.
Practical Steps
This classification will later guide your time allocation.
2. Build a Strong Conceptual
Foundation
Medical entrance exams test conceptual understanding, not rote
memorization.
Subject-Wise Focus
Biology
Physics
Chemistry
Golden Rule
If you cannot explain a concept in simple words, you have not truly
understood it.
3. Choose the Right Study Material
Using too many books creates confusion.
Ideal Resources
Quality matters more than quantity.
Recommended Approach
4. Create a Realistic Study Plan
A good timetable is flexible, achievable, and personalized.
Daily Structure Example
Weekly Structure
Important Principle
Consistency beats intensity.
Studying 6 hours daily for a year is better than 14 hours daily for two
months.
5. Master Active Learning Techniques
Passive reading is ineffective.
Effective Techniques
Example
Instead of reading respiration:
Ask:
6. Practice Questions Daily
Practice transforms knowledge into performance.
Types of Questions
Suggested Ratio
For every 1 hour of study → 1 hour of practice
Maintain a notebook for:
Revise this notebook weekly.
7. Regular Revision Strategy
Without revision, forgetting is inevitable.
The 3-Level Revision Rule
1.
Same day revision
2.
Weekly revision
3.
Monthly revision
Tools for Revision
Revision converts short-term memory into long-term memory.
8. Take Mock Tests Seriously
Mock tests simulate the real exam environment.
Benefits
After Every Mock Test
Improvement happens in analysis, not just in attempting tests.
9. Strengthen Time Management
In medical entrance exams, speed is crucial.
Tips
Practice solving questions within time limits.
10. Develop Exam Temperament
Many capable students fail due to panic.
Build Mental Toughness By:
Confidence comes from preparation.
11. Take Care of Physical Health
Your brain cannot function optimally in a weak body.
Essentials
Avoid excessive caffeine and junk food.
12. Protect Your Mental Health
Long preparation periods can cause anxiety, burnout, and self-doubt.
Healthy Practices
Everyone’s journey is different.
13. Role of Parents and Teachers
Supportive guidance enhances success.
Parents should:
Teachers should:
14. Avoid Common Mistakes
Awareness of mistakes prevents repetition.
15. Last 2–3 Months Strategy
Focus On
Avoid
Stability is key.
16. One-Month Before Exam
Do not try to “learn everything.” Strengthen what you already know.
17. On Exam Day
18. The Right Mindset
Medical entrance preparation is a marathon, not a sprint.
You will face:
These do not define your potential.
What defines you is:
Consistency + Discipline + Persistence
Conclusion
Preparing for medical entrance exams is a life-shaping experience. Beyond
securing a seat in medical college, it teaches patience, discipline,
resilience, and self-belief. Success does not belong only to geniuses; it
belongs to those who show up every day and do the work, even when motivation
fades.
If you remain consistent, revise regularly, practice wisely, and take
care of your mental and physical health, success will eventually follow.
Dream of becoming a doctor, but work like one today.